1-11 of 11
Yoshihiro Oka
Close
Sort by
Journal Articles

Dendritic cell vaccination as postremission treatment to prevent or delay relapse in acute myeloid leukemia

Clinical Trials & Observations
Sébastien Anguille, Ann L. Van de Velde, Evelien L. Smits, Viggo F. Van Tendeloo, Gunnar Juliusson, Nathalie Cools, Griet Nijs, Barbara Stein, Eva Lion, Ann Van Driessche, Irma Vandenbosch, Anke Verlinden, Alain P. Gadisseur, Wilfried A. Schroyens, Ludo Muylle, Katrien Vermeulen, Marie-Berthe Maes, Kathleen Deiteren, Ronald Malfait, Emma Gostick, Martin Lammens, Marie M. Couttenye, Philippe Jorens, Herman Goossens, David A. Price, Kristin Ladell, Yoshihiro Oka, Fumihiro Fujiki, Yusuke Oji, Haruo Sugiyama, Zwi N. Berneman
Journal: Blood
Blood (2017) 130 (15): 1713–1721.
https://doi.org/10.1182/blood-2017-04-780155
Published: 2017
Includes: Supplemental data
Journal Articles

Clinical Phase II Study of WT1 Peptide Vaccination in Pediatric Leukemia Patients after Stem Cell Transplantation and Analysis of Immunological Monitoring

Yoshiko Hashii, MD, PhD, Yoshihiro Oka, MD, PhD, Takako Miyamura, MD, PhD, Yusuke Oji, MD, PhD, Naoki Hosen, MD, PhD, Akihiro Tsuboi, MD, PhD, Haruo Sugiyama, MD, PhD, Keiichi Ozono, MD, PhD
Journal: Blood
Blood (2014) 124 (21): 672.
https://doi.org/10.1182/blood.V124.21.672.672
Published: 2014
Journal Articles

Long-Term WT1 Peptide Vaccination Over 7 Years for 3 AML Patients with Molecular Relapse

Haruo Sugiyama, MD, PhD, Akihiro Tsuboi, Yoshihiro Oka, MD, PhD, Taiichi Kyo, Yuuta Katayama, Elisseeva Olga, Manabu Kawakami, Naoki Hosen, Sumiyuki Nishida, Soyoko Morimoto, Ayako Murao, Hiroko Nakajima, Ichiro Kawase, Yusuke Oji, MD, PhD, Hiroo Dohy
Journal: Blood
Blood (2010) 116 (21): 3295.
https://doi.org/10.1182/blood.V116.21.3295.3295
Published: 2010
Journal Articles

WT1-Targeted Dendritic Cell Vaccination as A Post-Remission Treatment to Prevent Full Relapse In Acute Myeloid Leukemia

Zwi N. Berneman, MD, PhD, Ann an de Velde, MD, Sébastien Anguille, MD, Nathalie Cools, PhD, Ann Van Driessche, MSc, Katrien Vermeulen, PhD, Katrien Pieters, PhD, Griet Nijs, MT, Barbara Stein, MSc, Evelien L. Smits, PhD, Wilfried A. Schroyens, MD, PhD, Alain P. Gadisseur, MD, PhD, Inge Vrelust, MD, I. Jolanda de Vries, PhD, Kristin Ladell, PhD, Emma Gostick, PhD, David A. Price, MD, PhD, Yusuke Oji, MD, PhD, Yoshihiro Oka, MD, PhD, Haruo Sugiyama, MD, PhD, Viggo F. Van Tendeloo, PhD
Journal: Blood
Blood (2010) 116 (21): 16.
https://doi.org/10.1182/blood.V116.21.16.16
Published: 2010
Journal Articles

Prognostic Significance of WT1 mRNA and Anti-WT1 Antibody Levels in Peripheral Blood in Patients with Myelodysplastic Syndromes.

Hideto Tamura, MD, PhD, Kazuo Dan, Norio Yokose, Rika Iwakiri, Masatsugu Ohta, Hisashi Sakamaki, Kaoru Tohyama, Kondo Asaka, Hideya Hyodo, Kyoko Nakamura, Taishi Yamashita, Olga A Elisseeva, Yoshihiro Oka, Yusuke Oji, Haruo Sugiyama, Kiyoyuki Ogata
Journal: Blood
Blood (2009) 114 (22): 3821.
https://doi.org/10.1182/blood.V114.22.3821.3821
Published: 2009
Journal Articles

AML1-ETO rapidly induces acute myeloblastic leukemia in cooperation with the Wilms tumor gene, WT1

Sumiyuki Nishida, Naoki Hosen, Toshiaki Shirakata, Keisuke Kanato, Masashi Yanagihara, Shin-ichi Nakatsuka, Yoshihiko Hoshida, Tsutomu Nakazawa, Yukie Harada, Naoya Tatsumi, Akihiro Tsuboi, Manabu Kawakami, Yoshihiro Oka, Yusuke Oji, Katsuyuki Aozasa, Ichiro Kawase, Haruo Sugiyama
Journal: Blood
Blood (2006) 107 (8): 3303–3312.
https://doi.org/10.1182/blood-2005-04-1656
Published: 2006
Journal Articles

Generation of tumor-specific, HLA class I–restricted human Th1 and Tc1 cells by cell engineering with tumor peptide–specific T-cell receptor genes

Takemasa Tsuji, Masaki Yasukawa, Junko Matsuzaki, Takayuki Ohkuri, Kenji Chamoto, Daiko Wakita, Taichi Azuma, Hironari Niiya, Hiroyuki Miyoshi, Kiyotaka Kuzushima, Yoshihiro Oka, Haruo Sugiyama, Hiroaki Ikeda, Takashi Nishimura
Journal: Blood
Blood (2005) 106 (2): 470–476.
https://doi.org/10.1182/blood-2004-09-3663
Published: 2005
Journal Articles

The usefulness of monitoring WT1 gene transcripts for the prediction and management of relapse following allogeneic stem cell transplantation in acute type leukemia

Clinical Trials & Observations
Hiroyasu Ogawa, Hiroya Tamaki, Kazuhiro Ikegame, Toshihiro Soma, Manabu Kawakami, Akihiro Tsuboi, Eui Ho Kim, Naoki Hosen, Masaki Murakami, Tatsuya Fujioka, Tomoki Masuda, Yuki Taniguchi, Sumiyuki Nishida, Yusuke Oji, Yoshihiro Oka, Haruo Sugiyama
Journal: Blood
Blood (2003) 101 (5): 1698–1704.
https://doi.org/10.1182/blood-2002-06-1831
Published: 2003
Journal Articles

Humoral immune responses against Wilms tumor gene WT1 product in patients with hematopoietic malignancies

Olga A. Elisseeva, Yoshihiro Oka, Akihiro Tsuboi, Kiyoyuki Ogata, Fei Wu, Eui Ho Kim, Toshihiro Soma, Hiroya Tamaki, Manabu Kawakami, Yusuke Oji, Naoki Hosen, Takeshi Kubota, Masashi Nakagawa, Tamotsu Yamagami, Akira Hiraoka, Machiko Tsukaguchi, Keiko Udaka, Hiroyasu Ogawa, Tadamitsu Kishimoto, Taisei Nomura, Haruo Sugiyama
Journal: Blood
Blood (2002) 99 (9): 3272–3279.
https://doi.org/10.1182/blood.V99.9.3272
Published: 2002
Journal Articles

Wilms' Tumor Gene (WT1) Competes With Differentiation-Inducing Signal in Hematopoietic Progenitor Cells

Kazushi Inoue, Hiroya Tamaki, Hiroyasu Ogawa, Yoshihiro Oka, Toshihiro Soma, Toyoshi Tatekawa, Yusuke Oji, Akihiro Tsuboi, Eui Ho Kim, Manabu Kawakami, Tetsu Akiyama, Tadamitsu Kishimoto, Haruo Sugiyama
Journal: Blood
Blood (1998) 91 (8): 2969–2976.
https://doi.org/10.1182/blood.V91.8.2969.2969_2969_2976
Published: 1998
Journal Articles

Aberrant Overexpression of the Wilms Tumor Gene (WT1) in Human Leukemia

Kazushi Inoue, Hiroyasu Ogawa, Yoshiaki Sonoda, Takafumi Kimura, Hideaki Sakabe, Yoshihiro Oka, Seigou Miyake, Hiroya Tamaki, Yusuke Oji, Tamotsu Yamagami, Toyoshi Tatekawa, Toshihiro Soma, Tadamitsu Kishimoto, Haruo Sugiyama
Journal: Blood
Blood (1997) 89 (4): 1405–1412.
https://doi.org/10.1182/blood.V89.4.1405
Published: 1997